CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $306,000 | +57.7% | 155,100 | 0.0% | 0.00% | – |
| Q4 2020 | $194,000 | -30.5% | 155,100 | 0.0% | 0.00% | – |
| Q3 2020 | $279,000 | -75.2% | 155,100 | +15.7% | 0.00% | -100.0% |
| Q2 2020 | $1,125,000 | +73.6% | 134,100 | +8.4% | 0.00% | 0.0% |
| Q1 2020 | $648,000 | +21.6% | 123,700 | +26.7% | 0.00% | – |
| Q4 2019 | $533,000 | +280.7% | 97,600 | +240.4% | 0.00% | – |
| Q3 2019 | $140,000 | -0.7% | 28,676 | +40.5% | 0.00% | – |
| Q2 2019 | $141,000 | -51.0% | 20,406 | -50.8% | 0.00% | – |
| Q1 2019 | $288,000 | -0.3% | 41,460 | +18.5% | 0.00% | – |
| Q1 2017 | $289,000 | -2.4% | 35,000 | 0.0% | 0.00% | – |
| Q4 2016 | $296,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
| ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
| AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
| Platform Technology Partners | 60,000 | $75,000 | 0.04% |
| PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
| HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
| Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
| Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
| Aries Wealth Management | 23,400 | $33,000 | 0.02% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |